Search - tctmd.com

Displaying 601 - 620 of 636

Sort: Relevancy | Date

News Conference News TCT 2012

TVT Registry Sparks Discussion on Device Evaluation, Treatment Comparisons

October 26, 2012

News Conference News TCT 2012

PARTNER: Benefits of TAVR Sustained Out to 3 Years

October 25, 2012

Presentation TCT 2012

PARTNER: Prognostic Value of Low Flow in Patients with Severe Aortic Stenosis

Presenter: Howard Herrmann

October 24, 2012

Presentation TCT 2012

PARTNER: Early and Late Outcomes of Transcatheter Valve-in-Valves for Failed Balloon Expandable Transcatheter Aortic Valves

Presenter: Raj Makkar

October 24, 2012

Presentation TCT 2012

Lessons from the PARTNER Trials

Presenter: Stuart Pocock

October 24, 2012

Presentation TCT 2012

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

Presenter: Samir Kapadia

October 24, 2012

News Conference News TCT 2012

Flexibility with Future Reform, Contract Negotiations Key to Career Success

October 24, 2012

Presentation TCT 2012

TCT-95. Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial

Presenter: Mathew Williams

October 23, 2012

News Conference News TCT 2012

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

October 23, 2012

News Conference News TCT 2012

Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach

October 23, 2012

Presentation TCT 2012

Update from the Randomized PARTNER 2A Trial

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

New Data from the PARTNER Continued Access (Non-randomized): Transfemoral Outcomes After TAVR

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

New Data from PARTNER Continued Access (Non-randomized): Transapical Outcomes After TAVR

Presenter: Todd Dewey

October 22, 2012

Presentation TCT 2012

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

Presenter: Neil Weissman

October 22, 2012

News Conference News TCT 2012

PARTNER Analyses Provide Important Insights into TAVR

October 22, 2012

News Conference News TCT 2012

Globalization of Innovation a ‘Must Have’ to Improve Health Care Delivery

October 22, 2012

Presentation TCT 2012

Candidates for Transcatheter Aortic Valve Replacement (TAVR): Fitting the Current PARTNERS Criteria?

Presenter: Michael J. Babcock, Luis Guzman, Steven Lavine, Joel Strom, Theodore Bass

January 03, 2012

News Conference News

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

November 09, 2011

News Conference News

PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. Surgery

November 09, 2011

Advertisement

TVT Registry Sparks Discussion on Device Evaluation, Treatment Comparisons

PARTNER: Benefits of TAVR Sustained Out to 3 Years

PARTNER: Prognostic Value of Low Flow in Patients with Severe Aortic Stenosis

PARTNER: Early and Late Outcomes of Transcatheter Valve-in-Valves for Failed Balloon Expandable Transcatheter Aortic Valves

Lessons from the PARTNER Trials

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

Flexibility with Future Reform, Contract Negotiations Key to Career Success

TCT-95. Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach

Update from the Randomized PARTNER 2A Trial

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

New Data from the PARTNER Continued Access (Non-randomized): Transfemoral Outcomes After TAVR

New Data from PARTNER Continued Access (Non-randomized): Transapical Outcomes After TAVR

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

PARTNER Analyses Provide Important Insights into TAVR

Globalization of Innovation a ‘Must Have’ to Improve Health Care Delivery

Candidates for Transcatheter Aortic Valve Replacement (TAVR): Fitting the Current PARTNERS Criteria?

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content